Subscribe Us

header ads

Recents

header ads

Dermal Fillers Market Size At Around US$ 13.4 Bn In 2030

The dermal fillers market would grow at a CAGR of 8.01% over the predicted time frame. The market is expected to increase in value from US$ 7.24 Bn in 2022 to US$ 13.4Bn in 2030.

Dermal Fillers Market Size 2022 To 2030

The on dermal fillers Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2100

Report Scope of the Dermal Fillers Market

Report CoverageDetails
Market Size in 2022

USD 7.24 Billion

Market Size by 2030

USD 13.4 Billion

Growth Rate from 2022 to 2030CAGR of 8.01%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredMaterial, Product, Drug Type, Application, End User, and Geography

A recent report provides crucial insights along with application based and forecast information in the Global Dermal fillers Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Dermal fillers market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Dermal fillers market are included as given below:

Dermal fillers Market Key Players

  • AbbVie, Inc.
  • HUADONG MEDICINE CO., LTD
  • BIOPLUS CO., LTD.
  • TEOXANE LABORATORIES
  • BIOHA LABORATORIES
  • Prollenium Medical Technologies 
  • Galderma
  • Merz Pharma
  • Suneva Medical
  • BIOXIS pharmaceuticals

Market Segments

By Material

  • Hyaluronic acid
  • Calcium hydroxyl apatite
  • Poly-L-lactic Acid
  • PMMA (Poly(methyl methacrylate))
  • Fat Fillers
  • Others

By Product

  • Non-biodegradable
  • Biodegradable
    • Temporary biodegradable
    • Semi-Permanent biodegradable

By Drug Type

  • Branded
  • Generic

By Application

  • Wrinkle Correction Treatment
  • Scar treatment
  • Lip enhancement
  • Restoration of volume
  • Others

By End User

  • Specialty and Dermatology Clinics
  • Clinics and Hospitals
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Report Objectives

  • To define, describe, and forecast the global dermal fillers market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the dermal fillers market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dermal Fillers Market 

5.1. COVID-19 Landscape: Dermal Fillers Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dermal Fillers Market, By Material

8.1. Dermal Fillers Market, by Material, 2022-2030

8.1.1. Hyaluronic acid

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Calcium hydroxyl apatite

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Poly-L-lactic Acid

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. PMMA (Poly(methyl methacrylate))

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Fat Fillers

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Dermal Fillers Market, By Product

9.1. Dermal Fillers Market, by Product, 2022-2030

9.1.1. Non-biodegradable

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Biodegradable

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Dermal Fillers Market, By Drug Type 

10.1. Dermal Fillers Market, by Drug Type, 2022-2030

10.1.1. Branded

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Generic

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Dermal Fillers Market, By Application

11.1. Dermal Fillers Market, by Application, 2022-2030

11.1.1. Wrinkle Correction Treatment

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Scar treatment

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Lip enhancement

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Restoration of volume

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Dermal Fillers Market, By End User

12.1. Dermal Fillers Market, by End User, 2022-2030

12.1.1. Specialty and Dermatology Clinics

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Clinics and Hospitals

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Others

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. OSAT

Chapter 13. Global Dermal Fillers Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Material (2017-2030)

13.1.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.1.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Material (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Material (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Material (2017-2030)

13.2.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.2.4. Market Revenue and Forecast, by Application (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Material (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.2.7. Market Revenue and Forecast, by Application (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Material (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.2.10. Market Revenue and Forecast, by Application (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Material (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Material (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Material (2017-2030)

13.3.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.3.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Material (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Material (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Material (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Material (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Material (2017-2030)

13.4.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.4.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Material (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Material (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Material (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Material (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Material (2017-2030)

13.5.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.5.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Material (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Material (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Drug Type (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. AbbVie, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. HUADONG MEDICINE CO., LTD

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BIOPLUS CO., LTD.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. TEOXANE LABORATORIES

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. BIOHA LABORATORIES

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Prollenium Medical Technologies

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Galderma

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Merz Pharma

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Suneva Medical

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. BIOXIS pharmaceuticals

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

Post a Comment

0 Comments